Zimmer Biomet Holdings (ZBH) has witnessed substantial financial interest, with many investment firms increasing their stake. For instance,
First American Bank,
Bridge Creek Capital Management, and
Northside Capital Management recently boosted their investments in the company. Alongside this,
IFM Investors,
Covea Finance, and
Czech National Bank have also purchased company shares.
The company continually delivers on financial performance with positive quarterly results
1 and an upgraded full-year guidance. One innovative stride of the company came from acquiring
Monogram Technologies, enabling enhancements to their robotics suite.
Their innovative iodine-infused implants gained approval in Japan, marking a first of its kind. The company also presented its medical advancements at the American Orthopedic Foot and Ankle Society Annual Conference.
Despite tariff uncertainties causing a lower profit forecast for 2025, investors expect value in the long run. However, not all is positive: Zimmer Biomet recently announced a lawsuit against Deloitte over a failed project.
Zimmer Biomet Holdings ZBH News Analytics from Fri, 24 Jan 2025 08:00:00 GMT to Sat, 27 Sep 2025 10:27:31 GMT -
Rating 6
- Innovation 7
- Information 8
- Rumor 1
